ClinicalTrials.gg

Drug

Hyperpolarized Xe-129 clinical trials

Also written HP 129Xe.

studies test it
15
open now
5
in phase 3
0
first study started
2015

Keep track of what changes. Save the hyperpolarized Xe-129 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

129Xe
6
Hyperpolarized Xe129
5
Initiation of CFTR Modulator
2
129-Xe
2
HP Xenon
2

Development codes

HP 129Xe
2
Xenon-129
1

Studies by the year they started

15 studies that test it; most in 2020 (5)

Studies that test hyperpolarized Xe-129, by start year
YearStudies
20151
20181
20191
20205
20211
20224
20241
20251

By phase

A phase 1/2 study counts in both.

Early Phase 1
3
Phase 1
3
Phase 2
4
Phase 4
5
No phase
1

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 0 · Other 15

Children's Hospital Medical Center, Cincinnati (6) · University of Kansas Medical Center (2) · Dr. Grace Parraga (1) · University of North Carolina, Chapel Hill (1) · Mario Castro, MD, MPH (1) · The Hospital for Sick Children (1) · University of Virginia (1) · Thunder Bay Regional Health Research Institute (1)

Often tested with

Tested in the same studies.

Benralizumab (1) · Perflutren (1)

Studies

Open first, then newest update. How each study uses hyperpolarized Xe-129 is read from its arms, and is right about nine times in ten.

Testing it · 15

Given in every arm · 2 — hyperpolarized Xe-129 is usual care beside what is tested

Codes

What other systems call hyperpolarized Xe-129 · ClinicalTrials.gg INT000620

  • MeSH (NLM) C000614971hyperpolarized Xe-129One source NLM
  • UNII (FDA) 726Q6M95ZAXENON XE-129, HYPERPOLARIZEDConfirmed FDA, NLM

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.